Recent Post
Actinium Pharmaceuticals (ATNM): Poised for Growth? Targeted Radiotherapy Conditioning Agent Shows...
Actinium Pharmaceuticals (ATNM) shares saw slight volatility on Tuesday, closing at $8.81 (-0.34%). However, recent announcements concerning the company's Iomab-ACT project could...
